Risa J Lavizzo-Mourey
CIK 1034465 · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
INTC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
500 W. MONROE ST.
CHICAGO, IL 60661
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MRK | Director | 1,000 | $145.27 | $145.3K | $0 | 7 | 2026-06-02 |
| GEHC | Director | 10,157 | $71.45 | $725.7K | $0 | 3 | 2025-05-30 |
| INTC | Director | 29,772 | $86.96 | $2.59M | $247.5K | 13 | 2024-05-10 |
| Better Therapeutics, Inc. (BTTX) Delisted | Director | 13,750 | $0.04 | $613 | $46.0K | 5 | 2023-12-20 |
| GE | Director | 5,016 | $285.64 | $1.43M | $97.5K | 24 | 2023-01-05 |
| GE HealthCare Technologies Inc. (GEHCV) Delisted | Director | 1,041 | — | — | $0 | 1 | 2023-01-05 |
| HESS CORP (HES) Delisted | Director | 44,379 | $160.40 | $7.12M | $175.1K | 14 | 2020-03-10 |
| GNW | Director | 13,000 | $8.91 | $115.8K | $46.0K | 17 | 2012-04-02 |
| BEC | Director | 2,100 | $8.23 | $17.3K | $0 | 5 | 2007-07-06 |
Recent Filings · Page 4 of 9
89 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-02 | INTC | Mixed | +2,173 | $0 | EDGAR |
| 2021-01-04 | GE | Grant (A) | — | $0 | EDGAR |
| 2020-10-01 | GE | Grant (A) | — | $0 | EDGAR |
| 2020-07-02 | GE | Grant (A) | — | $0 | EDGAR |
| 2020-06-02 | MRK | Grant (A) | — | $0 | EDGAR |
| 2020-05-18 | INTC | Grant (A) | — | $0 | EDGAR |
| 2020-04-02 | GE | Grant (A) | — | $0 | EDGAR |
| 2020-03-10 | HESS CORP (HES) Delisted | Grant (A) | +1,491 | $0 | EDGAR |
| 2020-02-03 | INTC | Mixed | +592 | $0 | EDGAR |
| 2020-01-03 | GE | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.